Down-regulation of miR-302b, an ESC-specific microRNA, in gastric adenocarcinoma

Cell Journal

Volumn 13, Issue 4, 2012, Pages 251-258

  Khalili, Mitra ^a   Sadeghizadeh, Majid ^a   Alimoghaddam, Kamran ^b   Malekzadeh, Reza ^c   Vasei, Mohammad ^b   Mowla, Seyed Javad ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer stem cells; Gastric cancer; MicroRNA; MiR 302b

Indexed keywords

COMPLEMENTARY DNA; MICRORNA; MICRORNA 320B; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CARCINOGENESIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DATA ANALYSIS; DNA SYNTHESIS; DOWN REGULATION; EMBRYONAL CARCINOMA STEM CELL; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MEDICAL RECORD; PLURIPOTENT STEM CELL; RANDOM SAMPLE; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STOMACH; STOMACH ADENOCARCINOMA; STUDENT T TEST; UPREGULATION; WILCOXON SIGNED RANKS TEST;

EID: 84858690667     PISSN: 22285806     EISSN: 22285814     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Alberts SR, Cervantes A, van de Velde CJ. Gastric cancer: epidemiology, pathology and treatment. Ann Oncol. 2003; 14(Suppl 2): ii31-ii 36.
2. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006; 12(3): 354-362. (Pubitemid 43329250)
3. Cho RW, Clarke MF. Recent advances in cancer stem cells. Curr Opin Genet Dev. 2008; 18(1): 48-53. (Pubitemid 351694448)
4. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene. 2004; 23(43): 7274-7282. (Pubitemid 39382161)
5. Martinez-Climent JA, Andreu EJ, Prosper F. Somatic stem cells and the origin of cancer. Clin transl Oncol. 2006; 8(9): 647-663.
6. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008; 9(2): 102-114.
7. Hatfield SD, Shcherbata HR, Fischer KA, Nakahara K, Carthew RW, Ruohola-Baker H. Stem cell division is regulated by the microRNA pathway. Nature. 2005; 435(7044): 974-978. (Pubitemid 40896325)
8. Carleton M, Cleary MA, Linsley PS. MicroRNAs and cell cycle regulation. Cell Cycle. 2007; 6(17): 2127-2132. (Pubitemid 47450412)
9. Jovanovic M, Hengartner MO. miRNAs and apoptosis: RNAs to die for. Oncogene. 2006; 25(46): 6176-6187. (Pubitemid 44527848)
10. Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu Rev Med. 2009; 60: 167-179.
11. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6(4): 259-269.
12. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, Dyrskjot L, et al. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res. 2008; 68(15): 6416-6424.
13. Ozen M, Creighton CJ, Ozdemir M, Ittmann M. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene. 2008; 27(12): 1788-1793. (Pubitemid 351380263)
14. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006; 9(3): 189-198. (Pubitemid 43357945)
15. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 2007; 8(10): R214.
16. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and nontumorous tissues. Oncogene. 2006; 25(17): 2537-2545.
17. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA. 2007; 297(17): 1901-1908. (Pubitemid 46707844)
18. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, et al. Micro-RNA profiling in kidney and bladder cancers. Uroloncol. 2007; 25(5): 387-392. (Pubitemid 47362758)
19. Barroso-del Jesus A, Lucena-Aguilar G, Menendez P. The miR-302-367 cluster as a potential stemness regulator in ESCs. Cell Cycle. 2009; 8(3): 394-398.
20. Barroso-delJesus A, Romero-Lopez C, Lucena-Aguilar G, Melen GJ, Sanchez L, Ligero G, et al. Embryonic stem cell-specific miR302-367 cluster: human gene structure and functional characterization of its core promoter. Mol Cell Biol. 2008; 28(21): 6609-6619.
21. Card DA, Hebbar PB, Li L, Trotter KW, Komatsu Y, Mishina Y, et al. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol. 2008; 28(20): 6426-6438.
22. Terry MB, Gaudet MM, Gammon MD. The epidemiology of gastric cancer. Semin Radiat Oncol. 2002; 12(2): 111-127. (Pubitemid 34522348)
23. Atlasi Y, Mowla SJ, Ziaee SA, Bahrami AR. OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer. 2007; 120(7):1598-1602. (Pubitemid 46355399)
24. Asadi MH, Mowla SJ, Fathi F, Aleyasin A, Asadzadeh J, Atlasi Y. OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor. Int J Cancer. 2011; 128(11): 2645-2652.
25. Babaie Y, Herwig R, Greber B, Brink TC, Wruck W, Groth D, et al. Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells. 2007; 25(2): 500-510. (Pubitemid 46232806)
26. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 2005; 122(6): 947-956. (Pubitemid 41345211)
27. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell. 2008; 132(4): 567-582. (Pubitemid 351253686)
28. Du Z, Jia D, Liu S, Wang F, Li G, Zhang Y, et al. Oct4 is expressed in human gliomas and promotes colony formation in glioma cells. Glia. 2009; 57(7): 724-733.
29. Berg JS, Goodell MA. An argument against a role for Oct4 in somatic stem cells. Cell Stem Cell. 2007; 1(4): 359-360. (Pubitemid 47506541)
30. Cantz T, Key G, Bleidissel M, Gentile L, Han DW, Brenne A, et al. Absence of OCT4 expression in somatic tumor cell lines. Stem Cells. 2008; 26(3): 692-697.
31. Liedtke S, Enczmann J, Waclawczyk S, Wernet P, Kogler G. Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell. 2007; 1(4): 364-366. (Pubitemid 47506539)
32. Suo G, Han J, Wang X, Zhang J, Zhao Y, Dai J. Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun. 2005; 337(4): 1047-1051. (Pubitemid 41505231)
33. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol. 2002; 12(9): 735-739. (Pubitemid 34455427)
34. Houbaviy HB, Murray MF, Sharp PA. Embryonic stem cell-specific MicroRNAs. Dev Cell. 2003; 5(2): 351-358. (Pubitemid 37006477)
35. Lin SL, Chang DC, Lin CH, Ying SY, Leu D, Wu DT. Regulation of somatic cell reprogramming through inducible mir-302 expression. Nucleic Acids Res. 2011; 39(3): 1054-1065.
36. Stenvang J, Silahtaroglu AN, Lindow M, Elmen J, Kauppinen S. The utility of LNA in microRNA-based cancer diagnostics and therapeutics. Semin Cancer Biol. 2008; 18(2): 89-102.
37. Khayatzadeh H, Rafiee MR, Shafaroudi Malekzadeh A, Malakootian M, Mowla SJ. Detection of miR-302, an ES-specific microRNA, in cancer cell lines and tissues. EJC. 2010; 8(7): 202.
38. Lin SL, Chang DC, Ying SY, Leu D, Wu DT. MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways. Cancer Res. 2010; 70(22): 9473-9482.